日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution Patterns

探索卡斯尔曼病和TAFRO综合征的临床多样性:一项关于淋巴结分布模式的日本多中心研究

Otsuka, Mizuna; Koga, Tomohiro; Sumiyoshi, Remi; Fukui, Shoichi; Kaneko, Yuko; Shimizu, Takayuki; Katsube, Atsushi; Yano, Shingo; Masaki, Yasufumi; Ide, Makoto; Yoshifuji, Hajime; Kitano, Masayasu; Sato, Yasuharu; Sawa, Naoki; Niiro, Hiroaki; Nakamura, Naoya; Fajgenbaum, David C; van Rhee, Frits; Kawakami, Atsushi

International Consensus Histopathological Criteria for Subtyping Idiopathic Multicentric Castleman Disease Based on Machine Learning Analysis

基于机器学习分析的特发性多中心Castleman病亚型国际共识组织病理学标准

Nishimura, Midori Filiz; Haratake, Tomoka; Nishimura, Yoshito; Nishikori, Asami; Sumiyoshi, Remi; Ujiie, Hideki; Kawahara, Yuri; Koga, Tomohiro; Ueki, Masao; Laczko, Dorottya; Oksenhendler, Eric; Fajgenbaum, David C; van Rhee, Frits; Kawakami, Atsushi; Sato, Yasuharu

Morphological and quantitative CT features of anterior mediastinal lesions in TAFRO syndrome and idiopathic multicentric Castleman disease

TAFRO综合征和特发性多中心Castleman病前纵隔病变的形态学和定量CT特征

Mohamed, Lamiaa; Umeda, Masataka; Tsutsui, Shin; Toya, Ryo; Umetsu, Ayaka; Otsuka, Mizuna; Endo, Yushiro; Shimizu, Toshimasa; Fukui, Shoichi; Sumiyoshi, Remi; Kawakami, Atsushi; Koga, Tomohiro

Distinct clinical outcomes based on multiple serum cytokine and chemokine profiles rather than autoantibody profiles and ultrasound findings in rheumatoid arthritis: a prospective ultrasound cohort study

基于多种血清细胞因子和趋化因子谱而非自身抗体谱和超声检查结果的类风湿性关节炎临床结局差异:一项前瞻性超声队列研究

Fukui, Shoichi; Michitsuji, Tohru; Endo, Yushiro; Nishino, Ayako; Furukawa, Kaori; Morimoto, Shimpei; Shimizu, Toshimasa; Umeda, Masataka; Sumiyoshi, Remi; Koga, Tomohiro; Iwamoto, Naoki; Tamai, Mami; Origuchi, Tomoki; van Schie, Karin A J; Ueki, Yukitaka; Eiraku, Nobutaka; Yoshitama, Tamami; Matsuoka, Naoki; Suzuki, Takahisa; Okada, Akitomo; Hamada, Hiroaki; Ayano, Masahiro; Hidaka, Toshihiko; Tsuru, Tomomi; Maeda, Takahiro; Huizinga, Tom W J; Toes, René E M; Kawakami, Atsushi; Kawashiri, Shin-Ya

Effectiveness of Etanercept Biosimilar Initiating for Etanercept-Naive Patients, Using Ultrasound, Clinical, and Biomarker Assessments in Outcomes of Real-World Therapy (ENPORT-NGSK Study): An Interventional, Multicenter, Open-Label, Single-Arm Clinical Trial

依那西普生物类似药用于依那西普初治患者的疗效:基于真实世界治疗结果的超声、临床和生物标志物评估(ENPORT-NGSK 研究):一项干预性、多中心、开放标签、单臂临床试验

Sumiyoshi, Remi; Kawashiri, Shin-Ya; Shimizu, Toshimasa; Koga, Tomohiro; Kiya, Rieko; Tashiro, Shigeki; Kawazoe, Yurika; Sato, Shuntaro; Ueki, Yukitaka; Suzuki, Takahisa; Yoshitama, Tamami; Tada, Yoshifumi; Hosogaya, Naoki; Yamamoto, Hiroshi; Kawakami, Atsushi

Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease

特发性多中心性卡斯尔曼病(iMCD)特发性浆细胞性淋巴结病(IPL)亚型的诊断挑战:与IgG4相关疾病鉴别的因素

Nishikori, Asami; Nishimura, Midori Filiz; Fajgenbaum, David C; Nishimura, Yoshito; Maehama, Kanna; Haratake, Tomoka; Tabata, Tetsuya; Kawano, Mitsuhiro; Nakamura, Naoya; Momose, Shuji; Sumiyoshi, Remi; Koga, Tomohiro; Yamamoto, Hidetaka; van Rhee, Frits; Kawakami, Atsushi; Sato, Yasuharu

A Phase Ib Investigator-Initiated Trial of Filgotinib in Patients With Idiopathic Multicentric Castleman Disease

一项由研究者发起的 Ib 期临床试验,评估 Filgotinib 治疗特发性多中心 Castleman 病患者的疗效

Fukui, Shoichi; Sumiyoshi, Remi; Koga, Tomohiro; Hosogaya, Naoki; Narita, Sawana; Morimoto, Shimpei; Yano, Hiroshi; Katsube, Atsushi; Yano, Shingo; Masaki, Yasufumi; Tsunoda, Shinichiro; Sato, Shuzo; Migita, Kiyoshi; Matsuyama, Kazuko; Kato, Naoki; Kawamoto, Atsuhiko; Kawakami, Atsushi

Dynamics of Serum Cytokines and Chemokines in Patients With Idiopathic Multicentric Castleman Disease: From a Phase Ib Investigator-Initiated Trial of Filgotinib

特发性多中心Castleman病患者血清细胞因子和趋化因子的动态变化:来自一项Filgotinib Ib期研究者发起的试验

Fukui, Shoichi; Sumiyoshi, Remi; Koga, Tomohiro; Hosogaya, Naoki; Narita, Sawana; Morimoto, Shimpei; Yano, Hiroshi; Katsube, Atsushi; Yano, Shingo; Masaki, Yasufumi; Tsunoda, Shinichiro; Sato, Shuzo; Migita, Kiyoshi; Kawakami, Atsushi

A Phase-II Investigator-Initiated Randomized, Double-Blind, Parallel-Group Clinical Trial of 5-Aminolevulinic Acid Hydrochloride/Sodium Ferrous Citrate (5-ALA-HCl/SFC) for Patients With Adult-Onset Still's Disease (AOSD) Refractory to Corticosteroids

一项由研究者发起的 II 期随机、双盲、平行组临床试验,评估 5-氨基乙酰丙酸盐酸盐/柠檬酸亚铁钠 (5-ALA-HCl/SFC) 治疗对皮质类固醇治疗无效的成人斯蒂尔病 (AOSD) 患者的疗效

Sumiyoshi, Remi; Koga, Tomohiro; Kamisawa, Osamu; Morimoto, Shimpei; Hosogaya, Naoki; Yamamoto, Hiroshi; Kawakami, Mariko; Inaba, Yosuke; Hattori, Yoko; Hikake, Tamiki; Kurokawa, Tomoya; Hanaoka, Hideki; Sato, Shuzo; Migita, Kiyoshi; Ogawa, Noriyoshi; Hashimoto, Motomu; Kawakami, Atsushi

A Placebo-Controlled Exploratory Trial of Sirolimus for Tocilizumab-Resistant Idiopathic Multicentric Castleman Disease: Early Termination and Long-Term Extension Results Based on Descriptive Results From Two Patients

一项针对托珠单抗耐药性特发性多中心Castleman病患者的西罗莫司安慰剂对照探索性试验:基于两名患者的描述性结果的早期终止和长期扩展结果

Koga, Tomohiro; Sumiyoshi, Remi; Shimizu, Toshimasa; Hosogaya, Naoki; Fukushima, Chizu; Yamamoto, Hiroshi; Yoshifuji, Hajime; Higa, Shinji; Kawakami, Atsushi